# A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Fenfluramine (Hydrochloride) in Infants 1 Year to Less Than 2 Years of Age With Dravet Syndrome

> **NCT06118255** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **UCB BIOSCIENCES, Inc.** · enrollment: 25 (actual)

## Conditions studied

- Dravet Syndrome

## Interventions

- **DRUG:** fenfluramine

## Key facts

- **NCT ID:** NCT06118255
- **Lead sponsor:** UCB BIOSCIENCES, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-05-21
- **Primary completion:** 2026-09-03
- **Final completion:** 2026-12-16
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2026-04-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06118255

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06118255, "A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Fenfluramine (Hydrochloride) in Infants 1 Year to Less Than 2 Years of Age With Dravet Syndrome". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06118255. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*